Tocilizumab |
rhPM-1; RO-48775533; RG-1569; MRA; HPM-1; MRA-SC; R-1569 |
Approved |
Chugai Pharmaceutical Co Ltd |
Actemra, RoActemra, 雅美罗, Actemra/RoActemra, Acterma |
Japan |
Arthritis, Rheumatoid; Giant Cell Arteritis; Takayasu Arteritis; Cytokine Release Syndrome; Multicentric Castleman's Disease (MCD); Arthritis, Juvenile |
null |
2005-04-11 |
Uveitis, Posterior; Polymyalgia Rheumatica; Takayasu Arteritis; Multicentric Castleman's Disease (MCD); systemic sclerosis-associated interstitial lung disease; Breast Neoplasms; Coronavirus Infections; Lupus Erythematosus, Systemic; Coronary Disease; Pulmonary Arterial Hypertension; Fever; Coronaviridae Infections; Lymphoma; Pleural Effusion, Malignant; Stroke; Inflammation; Rejection in heart transplantation; Pulmonary Disease, Chronic Obstructive; Uveitis; Osteoarthritis; Panuveitis; Non-ST Elevated Myocardial Infarction; Carcinoma, Hepatocellular; Anemia, Sickle Cell; Diabetes Mellitus; Behcet Syndrome; Amyotrophic Lateral Sclerosis; Kidney Failure, Chronic; Myocardial Infarction; Solid tumours; Non-radiographic axial spondyloarthritis; Cytokine Release Syndrome; HIV Infections; Acute Chest Syndrome; Diabetes Mellitus, Type 1; Craniopharyngioma; Motor Neuron Disease; Polymyositis; Schnitzler Syndrome; Giant Cell Arteritis; Uveitis, Intermediate; Pneumonia; Hematologic Neoplasms; Polyarticular Juvenile Idi |
Details
|
Tocilizumab biosimilar (Bio-Thera Solutions) |
BAT-1806; BIIB-800 |
Approved |
Bio-Thera Solutions Ltd |
施瑞立, TOFIDENCE |
Mainland China |
Arthritis, Rheumatoid; Arthritis, Juvenile; Cytokine Release Syndrome |
Bio-Thera Solutions Ltd |
2023-01-16 |
Cytokine Release Syndrome; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Arthritis, Juvenile |
Details
|
Satralizumab |
RG-6168; SA-237 |
Approved |
Chugai Pharmaceutical Co Ltd |
Enspryng, エンスプリング |
Japan |
Neuromyelitis Optica |
Chugai Pharmaceutical Co Ltd |
2020-06-29 |
Myasthenia Gravis; Brain Ischemia; Graves Ophthalmopathy; Neuromyelitis Optica; Pulmonary Arterial Hypertension; Encephalitis; Subarachnoid Hemorrhage; Anti-N-Methyl-D-Aspartate Receptor Encephalitis |
Details
|
Sarilumab |
SAR-153191; REGN-88 |
Approved |
Sanofi, Regeneron Pharmaceuticals Inc |
Kevzara |
United States |
Arthritis, Rheumatoid |
Sanofi-Synthelabo |
2017-05-22 |
Non-radiographic axial spondyloarthritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Sarcoidosis; Mastocytosis, Systemic; Arthritis, Juvenile; Polymyalgia Rheumatica; Severe Acute Respiratory Syndrome; Uveitis |
Details
|
Tocilizumab biosimilar (Livzon Group) |
LZM-008 |
Approved |
Livzon Pharmaceutical Group Inc |
安维泰 |
Mainland China |
Arthritis, Rheumatoid |
Livzon Mabpharm Inc |
2023-01-18 |
Arthritis, Rheumatoid |
Details
|
Tocilizumab biosimilar (Fresenius kabi) |
MSB-11456 |
Approved |
Merck Serono |
Tyenne® |
EU |
Cytokine Release Syndrome; Arthritis, Rheumatoid; Giant Cell Arteritis; Coronavirus Disease 2019 (COVID-19) |
Fresenius Kabi Deutschland Gmbh |
2023-09-15 |
Cytokine Release Syndrome; Giant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19) |
Details
|